1. Introduction {#sec1}
===============

The presence of chronic kidney disease (CKD) enhances the likelihood of cardiovascular disease (CVD) hospitalizations and death \[[@B1]\]. Even modest kidney function impairment is associated with a significant increase in cardiovascular risk \[[@B2]\]. The relationship of traditional factors for CVD such hypertension, diabetes, and proteinuria also contribute, to progressive renal function decline. However the significantly higher risk of CVD in patients with CKD is not fully explained by traditional factors; thus, there remains interest in investigating the association of less traditional risk factors, such as central blood pressure measurements, with both CVD and the progression of CKD \[[@B3]\].

The last three decades have witnessed a remarkable increase in the usage of invasive and noninvasive methods to estimate central blood pressure profiles \[[@B4]\]. Many of these approaches are based on tonometric assessment of waveforms or the velocity of pulse wave travel in the aorta. A recent meta-analysis of the usefulness of central pressure measurements for predicting CVD events concluded that the augmentation index provided independent CVD predictive utility when modeled together with traditional blood pressure measures for this outcome \[[@B5]\]. These devices have facilitated the incorporation of measures of central blood pressure into a number of observational prospective studies in the CKD population. Several studies in the end-stage kidney disease (ESKD) population have testified to the value of central pressure measurements for CVD events but less research has focused on the predialysis CKD population, particularly with CKD progression as the outcome of interest. This paper will focus on cross-sectional and longitudinal associations between central blood pressure measurements in the predialysis CKD population and specifically directed toward CKD outcomes. Several approaches have been taken to study arterial structure and function. These are generally categorized as:

1.  those that measure large artery function as reflected by determinations of large artery stiffness which is usually assumed to be represented by the velocity of pulse wave travel in the vessel(s) of interest \[[@B6]\]

2.  those that measure the effects of aspects of wave reflection such as augmentation index, central systolic and central pulse pressure \[[@B6]\].

This paper will focus mainly on investigations using the second approach. In some studies both have been used, but these tend to be exceptions rather than the rule.

2. Wave Reflection {#sec2}
==================

Before reviewing studies using technology that quantify the effect of wave reflection on the central circulation it is important to review, briefly, the physiology of wave reflection and define the terms used in this area of research.

The shape, and the magnitude of the arterial waveform changes as the wave travels from the heart to the periphery as shown in [Figure 1](#fig1){ref-type="fig"}. For the purpose of the current paper note that the *pulse pressure* (defined as the systolic pressure---diastolic pressure) increases as the pressure wave travels to the periphery. This phenomenon is termed pulse pressure augmentation and results from the interaction of the forward and backward traveling pressure waves which, summate algebraically as shown in [Figure 2](#fig2){ref-type="fig"}. Depending on where the measurement is made in the circulation the waveform will vary in shape and magnitude depending on its relative location to wave reflecting sites. Wave reflection results from changes in vascular *impedance* (defined as the relationship of pressure divided by flow). Things that change vascular impedance include branching, plaque, and changes in vascular caliber for example. If there were no changes in vascular impedance, each pressure wave would simply assume the shape of a flow wave. Since there are changes in vascular impedance, their effect modifies the forward traveling pressure wave as shown in [Figure 3](#fig3){ref-type="fig"}. The change in systolic contour in the shaded area of [Figure 3](#fig3){ref-type="fig"} represents the effect of wave reflection. This is usually quantified either by determining the difference between the peak systolic pressure (P2) divided by the central pulse pressure (called the *augmentation index, (AIx)*) or by determining the degree of augmented pressure by subtracting P1 from P2 (called the *augmentation pressure, (AP)*). The rest of [Figure 3](#fig3){ref-type="fig"} depicts the terminology used for a representative central pressure waveform. [Figure 4](#fig4){ref-type="fig"} shows typical waveforms obtained from the radial artery with corresponding aortic pressure profiles illustrating the effects of age on waveform reflection (in a CKD cohort). Other determinants of wave reflection include heart rate \[[@B7]\], height/gender \[[@B9], [@B8]\], medications \[[@B10]\], and various comorbidities such as hypertension, diabetes, and other standard CVD risk factors \[[@B11]\]. Several reviews are available to consult for a more in depth study of reflected wave physiology \[[@B12]--[@B14]\].

3. Studies of Central Pressure: Profiling CKD Progression {#sec3}
=========================================================

One of the earliest investigations of arterial waveform analysis and CKD progression was undertaken by Takenaka et al. in a Japanese cohort of nondiabetic CKD patients using radial artery tonometry \[[@B15]\]. In 41 patients with a mean baseline creatinine clearance of 52 mL/min they reported that a higher radial AIx value, along with higher baseline urine protein excretion were the only significant factors in their multiple regression analysis for the decline in creatinine clearance 1 year later.

Taal et al. building on the Takenaka study, expanded the relevant variables studied in a slightly smaller sample size (*n* = 35) of stage 4 and 5 CKD patients and pursued the endpoint of ESKD defined as commencing dialysis more than 30 days after enrollment \[[@B16]\]. Over a period of slightly more than one year 22 of the 35 study participants commenced dialysis. Baseline eGFR, urine protein excretion, cigarette usage, higher PWV and an AIx above the median value (of 43%) were all shown to be independent predictors for progression onto dialysis.

The chronic renal insufficiency cohort (CRIC) ancillary study has measured central aortic PP (CPP) using radial tonometry since 2005. One of the aims of the study was to determine clinical factors independently associated with CPP in CKD and to evaluate how well brachial PP correlates with CPP in a large ethnically diverse population of CKD. The CRIC study measured central pulse pressure cross-sectionally in 2531 participants in the CRIC study to determine correlates of the magnitude of central pulse pressure in the setting of CKD. In the cross-sectional analysis central pulse pressure measurements tertiles were \<36 mmHg, 36--51 mmHg and \>51 mmHg with an overall mean CPP of 46 mmHg and a mean brachial PP of 57 mmHg. An increasing proportion of those subjects within each worsening CKD stage had a central pulse pressure ≥ 50 mmHg ([Figure 5](#fig5){ref-type="fig"}) \[[@B17]\].

Data from the CRIC study were analyzed longitudinally to determine *which* central hemodynamic measure (central systolic pressure, AIx, AP, and central pulse pressure) had the best predictive potential for death and kidney function decrement endpoints. To date the following data have only been presented in abstract form \[[@B18]\].

Approximately half of the CRIC participants were females with a mean age of 60 years and a mean eGFR of 41 mL/min/1.73 m^2^. The events analyzed were (1) death, (2) ESKD (*n* = 99) or (3) a 50% reduction in eGFR from baseline or ESKD ("RENAL1" endpoint; *n* = 129). Death was treated as a censoring event for the renal events. [Figure 6](#fig6){ref-type="fig"} (redrawn from the abstract \[[@B18]\]) displays the hazard ratios (adjusted for age, race, sex, diabetes, eGFR, proteinuria, and clinical site) with the different independent variables categorized using common clinical cut-points for brachial systolic/pulse pressures, and central aortic systolic/pulse/ augmentation pressures and aortic pulse wave velocity. These findings suggested that in CKD

1.  increasing PWV predicts ESKD,

2.  central pressures also predict ESKD,

3.  central pulse pressure appears to predict ESKD best among the four selected measures of central pressure.

4. Speculations {#sec4}
===============

Given the paucity of studies of CKD progression, and the limitations of noninvasive technology to pursue mechanisms of progressive kidney damage, it is difficult to state with certainty how increasing pulse pressure mediates increasing kidney function loss. Loutzenhiser et al. and others, have stressed relative importance of afferent arterial myogenic tone, and its relationship to tubuloglomerular feedback \[[@B19]\]. It stands to reason then, that in an organ like the kidney, whose blood flow (relative to mass) has been described as "torrential" \[[@B20]\], increasing pulse pressure would act like a progressively heavy hammer slamming into the delicate capillary network of the glomerulus particularly when the afferent arteriole fails as a gatekeeper to buffer the incoming pressure waveform. Their work in animal models suggest the systolic pressure is important in influencing afferent arteriolar myogenic responses \[[@B21]\]. Whether this is the most important hemodynamic parameter in humans, especially given the variety of processes associated with CKD (diabetes, glomerulonephritis, etc.), is not as clear. The morphometric work of Gary Hill supports this concept. He has shown that larger afferent arterioles (on kidney biopsy) in hypertension correlate positively to the size of the glomerulus and also predict the likelihood of finding focal sclerosis \[[@B22]\]. Moreover, it seems plausible to these authors that when a higher pulse pressure is delivered at a greater velocity (courtesy of increasing central arterial stiffness) the damaging effect of the higher pulse pressure would be amplified by the higher velocity of delivery because of the greater energy dispersion into tissues associated with higher PWV values.

![Changes in arterial pressure wave contour between ascending aorta and femoral artery (adapted from reference \[[@B9]\]).](IJN2011-407801.001){#fig1}

![Pictorial representation of summation (right) effects on the arterial pressure waveform resulting from forward (left) and backward (i.e., "reflected"; middle) wave integration.](IJN2011-407801.002){#fig2}

![Pictorial representation of central vessel waveform. P1 represents the pressure effected by the forward traveling wave. P2 minus P1 represents the amount of systolic pressure augmentation attributed to the reflected wave. P2 minus the diastolic blood pressure (DBP) is the central pulse pressure. The augmentation pressure (P2-P1) divided by the central pulse pressure is the Augmentation Index. The shaded area in the waveform estimates the effect of the reflected wave form on systolic workload.](IJN2011-407801.003){#fig3}

###### 

Representative wave forms showing the effect of aging on the radial (left) and aortic (right) pulse contours from subjects studied in the CRIC.
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![Increasing prevalence of central pulse pressure values \> 50 mmHg among 2531 participants in the Chronic Renal Insufficiency Cohort (CRIC) (redrawn from \[[@B17]\]).](IJN2011-407801.005){#fig5}

![Referent groups are \<120/\<80 for brachial BP, \<8 m/sec for aortic pulse wave velocity (PWV), \<25 mmHg for central pulse pressure (PP), \<20% for central augmentation index (AIx), \<100 for central systolic blood pressure (SBP), and \<8 mmHg for the augmented (Aug) central pressure wave. Endpoints were death (black diamond), end-stage kidney disease (ESKD, red hexagon) and doubling of serum creatinine or ESKD or death (blue circle).](IJN2011-407801.006){#fig6}
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